MRK
35
-5
MTB
65
-3
LH
46
-2
KSS
26
3
KEY
41
-2
MAC
65
-3
KLAC
57
4
PNW
67
-3
PSX
49
2
HCA
48
2
RIG
61
6
DRI
60
2
AVB
65
-2
URBN
76
10
LMT
32
2
SE
61
-4
HCP
62
2
FIS
46
-2
HSY
40
3
BDX
52
10
MRK
35
-5
MTB
65
-3
LH
46
-2
KSS
26
3
KEY
41
-2
MAC
65
-3
KLAC
57
4
PNW
67
-3
PSX
49
2
HCA
48
2
RIG
61
6
DRI
60
2
AVB
65
-2
URBN
76
10
LMT
32
2
SE
61
-4
HCP
62
2
FIS
46
-2
HSY
40
3
BDX
52
10
Financhill
Back

ProShares Ultra MSCI Brazil Capped Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
27

UBR
ProShares Ultra MSCI Brazil Capped

Last Price:
16.76
Seasonality Move:
7.35%
Sell
25

DRUG
Bright Minds Biosciences

Last Price:
43.34
Seasonality Move:
-15.89%
Sell
27
ProShares Ultra MSCI Brazil Capped (UBR) is a Sell

Is ProShares Ultra MSCI Brazil Capped a Buy, Sell or Hold?

  • The current ProShares Ultra MSCI Brazil Capped [UBR] share price is $16.73. The Score for UBR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • UBR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UBR Stock Price Chart

What is ProShares Ultra MSCI Brazil Capped's stock price today?

  • The ProShares Ultra MSCI Brazil Capped share price today is $16.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UBR is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $44.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

UBR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.75 Sell
Relative Strength Index (14 RSI): 24.96 Sell
Chaikin Money Flow: -585 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.78 - 20.7) Sell
Bollinger Bands (100): (20.02 - 23.82) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.5 Buy
Relative Strength Index (14 RSI): 58.93 Buy
Chaikin Money Flow: 115403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.12 - 49.42) Buy
Bollinger Bands (100): (-5.11 - 34.85) Buy

UBR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.82 Sell
20-day SMA: 19.5 Sell
50-day SMA: 20.84 Sell
200-day SMA: 23.9 Sell
8-day EMA: 18.6 Sell
20-day EMA: 19.39 Sell
50-day EMA: 20.55 Sell
200-day EMA: 23.29 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.17 Buy
20-day SMA: 42.3 Buy
50-day SMA: 28.61 Buy
200-day SMA: 8.06 Buy
8-day EMA: 39.27 Buy
20-day EMA: 39.13 Buy
50-day EMA: 31.07 Buy
200-day EMA: 12.97 Buy

ProShares Ultra MSCI Brazil Capped Earnings Growth & UBR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ProShares Ultra MSCI Brazil Capped Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):